Expand MLTX Menu
MLTX MENU

MLTX Latest Press Releases

-- March 28, 2026 --

MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting Globe Newswire 3:00 PM

-- February 22, 2026 --

MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results Globe Newswire 11:00 AM

-- February 10, 2026 --

ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer Globe Newswire 7:00 AM

-- February 2, 2026 --

MoonLake Announces FDA Fast Track Designation for Sonelokimab Palmoplantar Pustulosis (PPP) and Provides Details on Upcoming Investor Day Globe Newswire 8:00 AM

-- January 8, 2026 --

Morning Market Pulse: From Orbit to Biomaterials, Innovation Drives the Tape Globe Newswire 9:32 AM
MoonLake Immunotherapeutics Announces Positive Outcome from Type B Meeting with U.S. FDA and Announces Investor Day Globe Newswire 8:00 AM

-- December 15, 2025 --

Contact Levi & Korsinsky by December 15, 2025 Deadline to Join Class Action Against MoonLake Immunotherapeutics(MLTX) Globe Newswire 3:49 PM
MLTX DEADLINE ALERT: Hagens Berman Alerts MoonLake (MLTX) Investors to Today's Lead Plaintiff Deadline in Securities Class Action PRNewswire 1:01 PM
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX Business Wire 12:00 PM
MOONLAKE DECEMBER 15th DEADLINE: Bragar Eagel & Squire, P.C. Urgently Reminds MoonLake Immunotherapeutics Investors to Contact the Firm Globe Newswire 10:46 AM
Portnoy Law Firm Announces Class Action on Behalf of Moonlake Immunotherapeutics, Inc. Investors Globe Newswire 10:20 AM
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics Business Wire 9:34 AM
Shareholders that lost money on MoonLake Immunotherapeutics(MLTX) Urged to Join Class Action - Contact The Gross Law Firm to Learn More PRNewswire 9:00 AM
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm Business Wire 8:55 AM
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX PRNewswire 3:27 AM
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm PRNewswire 3:25 AM

-- December 14, 2025 --

MLTX DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages MoonLake Immunotherapeutics Investors with Losses in Excess of $100K to Secure Counsel Before Important December 15 Deadline in Securities Class Action - MLTX Globe Newswire 9:00 AM

-- December 13, 2025 --

MLTX 2-DAY DEADLINE ALERT: MoonLake (MLTX) Class Action Lawsuit - Hagens Berman Scrutinizing Nanobody Superiority Claims After 90% Plunge; December Lead Plaintiff Deadline Looms Globe Newswire 1:07 PM
MOONLAKE CLASS ACTION DEADLINE: Bragar Eagel & Squire, P.C. Urgently Reminds MoonLake Immunotherapeutics Investors to Contact the Firm Before December 15th Globe Newswire 9:21 AM
MLTX FRAUD UPDATE: Important MoonLake Immunotherapeutics Securities Fraud Class Action Deadline is Approaching for Investors - Contact BFA Law before December 15 Globe Newswire 7:18 AM

-- December 12, 2025 --

Deadline Soon: MoonLake Immunotherapeutics (MLTX) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit Business Wire 8:51 PM
MoonLake Immunotherapeutics Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MLTX Globe Newswire 4:31 PM
MLTX Deadline: MLTX Investors with Losses in Excess of $100K Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit PRNewswire 4:00 PM
MLTX Investor Deadline Alert: MoonLake (MLTX) Class Action Lawsuit - Hagens Berman Scrutinizing Nanobody Superiority Claims After 90% Plunge; December Lead Plaintiff Deadline Looms PRNewswire 11:46 AM
MLTX DEADLINE: Faruqi & Faruqi Reminds MoonLake Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 - MLTX PRNewswire 11:21 AM
MoonLake Immunotherapeutics Class Action: Levi & Korsinsky Reminds MoonLake Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 - MLTX PRNewswire 9:00 AM

-- December 11, 2025 --

DEADLINE ALERT for MLTX, BAX, JHX: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions Globe Newswire 8:40 PM
MLTX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important December 15 Deadline in Securities Class Action - MLTX Globe Newswire 6:25 PM
Investors who lost money on MoonLake Immunotherapeutics (MLTX) should contact The Gross Law Firm about pending Class Action - MLTX Globe Newswire 4:41 PM
MLTX 4-DAY DEADLINE ALERT: MoonLake (MLTX) Class Action Lawsuit - Hagens Berman Scrutinizing Nanobody Superiority Claims After 90% Plunge; December Lead Plaintiff Deadline Looms Globe Newswire 12:53 PM
MoonLake Immunotherapeutics Class Action: The Gross Law Firm Reminds MoonLake Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 - MLTX PRNewswire 9:00 AM
DEADLINE NEXT WEEK: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Contact the Firm Before December 15, 2025 PRNewswire 8:54 AM
MLTX INVESTOR NOTICE: MoonLake Immunotherapeutics Stock Dropped 90% after Drug Trial Results; Contact BFA Law about the Pending Securities Class Action Globe Newswire 8:08 AM
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX PRNewswire 8:02 AM
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm PRNewswire 7:37 AM

-- December 10, 2025 --

MOONLAKE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against MoonLake Immunotherapeutics and Encourages Investors to Contact the Firm Globe Newswire 6:14 PM
MLTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Globe Newswire 12:00 PM
MLTX Investor Deadline Alert: MoonLake (MLTX) Class Action Lawsuit - Hagens Berman Scrutinizing Nanobody Superiority Claims After 90% Plunge; December Lead Plaintiff Deadline Looms Business Wire 9:55 AM

-- December 9, 2025 --

MLTX LAWSUIT ALERT: Levi & Korsinsky Notifies MoonLake Immunotherapeutics Investors of a Class Action Lawsuit and Upcoming Deadline Globe Newswire 4:41 PM
MLTX 6-DAY DEADLINE ALERT: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman PRNewswire 12:46 PM
Portnoy Law Firm Announces Class Action on Behalf of MoonLake Immunotherapeutics, Inc. Investors Globe Newswire 9:11 AM
Investors in MoonLake Immunotherapeutics Should Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights - MLTX PRNewswire 9:00 AM
MLTX LAWSUIT ALERT: MoonLake Immunotherapeutics Hit with Securities Fraud Class Action after Drug Trial Results - Contact BFA Law if You Suffered Losses Globe Newswire 8:33 AM

-- December 8, 2025 --

Contact The Gross Law Firm by December 15, 2025 Deadline to Join Class Action Against MoonLake Immunotherapeutics(MLTX) Globe Newswire 3:09 PM
MLTX 1-WEEK DEADLINE ALERT: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman Globe Newswire 12:58 PM
MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PRNewswire 12:00 PM
DEADLINE APPROACHING: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Inquire About a Securities Fraud Class Action by December 15, 2025 Globe Newswire 10:45 AM
Contact The Gross Law Firm by December 15, 2025 Deadline to Join Class Action Against MoonLake Immunotherapeutics(MLTX) PRNewswire 9:00 AM
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm PRNewswire 3:23 AM
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX PRNewswire 2:26 AM

-- December 7, 2025 --

MLTX Deadline: MLTX Investors with Losses in Excess of $100K Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit PRNewswire 8:54 AM
MLTX INVESTOR LOSSES: Lose Money on MoonLake Immunotherapeutics? Contact BFA Law before December 15 Securities Class Action Deadline Globe Newswire 7:18 AM

-- December 6, 2025 --

MLTX 9-DAY DEADLINE ALERT: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman Globe Newswire 1:02 PM

-- December 5, 2025 --

MLTX IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages MoonLake Immunotherapeutics Investors with Losses in Excess of $100K to Secure Counsel Before Important December 15 Deadline in Securities Class Action - MLTX Globe Newswire 6:11 PM
Class Action Filed Against MoonLake Immunotherapeutics (MLTX) Seeking Recovery for Investors - Contact Levi & Korsinsky PRNewswire 3:30 PM
Deadline Alert: MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit Globe Newswire 12:00 PM
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics PRNewswire 11:13 AM
MoonLake Immunotherapeutics (MLTX) Investors are Encouraged to Act before the Upcoming December 15 Securities Fraud Deadline - Contact BFA Law if You Lost Money Globe Newswire 8:18 AM
MoonLake's (MLTX) SLK Efficacy Claims Under Scrutiny After 90% Plunge; Focus on Nanobody vs. BIMZELX Superiority- Hagens Berman PRNewswire 8:06 AM

-- December 4, 2025 --

Lost Money on MoonLake Immunotherapeutics(MLTX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky Globe Newswire 4:15 PM
DEADLINE ALERT for MLTX, BAX, and JHX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders Globe Newswire 12:08 PM
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics Globe Newswire 10:52 AM
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 15, 2025 in MoonLake Lawsuit - MLTX PRNewswire 9:00 AM
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX PRNewswire 7:52 AM
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm PRNewswire 7:51 AM

-- December 3, 2025 --

MoonLake Immunotherapeutics Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - MLTX Globe Newswire 4:21 PM
MoonLake's (MLTX) SLK Efficacy Claims Under Scrutiny After 90% Plunge; Focus on Nanobody vs. BIMZELX Superiority- Hagens Berman PRNewswire 3:05 PM
DEADLINE ALERT for ATYR, MLTX, BAX, JHX: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class Actions Globe Newswire 1:40 PM
MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds MoonLake Immunotherapeutics Investors of Upcoming Deadline Globe Newswire 12:15 PM
MLTX NEWS: MoonLake Immunotherapeutics Sued for Securities Fraud after Stock Plummets 90% -- Investors Notified to Contact BFA Law by December 15 Deadline Globe Newswire 7:46 AM

-- December 2, 2025 --

MLTX Deadline: MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit PRNewswire 5:52 PM
Bragar Eagel & Squire, P.C. Urges Investors of Cepton, and MoonLake to Inquire About Their Rights Before Upcoming Deadlines Globe Newswire 5:29 PM
MLTX Lawsuit: Hagens Berman Scrutinizing MoonLake's SLK Efficacy Claims After 90% Plunge; Focus on Nanobody vs. BIMZELX Superiority Globe Newswire 5:25 PM
MLTX FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important December 15 Deadline in Securities Class Action - MLTX Globe Newswire 3:54 PM
MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PRNewswire 12:00 PM
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights - MLTX PRNewswire 9:01 AM

-- December 1, 2025 --

MLTX Lawsuit: Hagens Berman Scrutinizing MoonLake's SLK Efficacy Claims After 90% Plunge; Focus on Nanobody vs. BIMZELX Superiority PRNewswire 8:38 PM
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of MoonLake Immunotherapeutics(MLTX) Shareholders Globe Newswire 4:15 PM
MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PRNewswire 12:00 PM
The Gross Law Firm Reminds MoonLake Immunotherapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 - MLTX PRNewswire 8:45 AM
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against MoonLake Immunotherapeutics (NASDAQ: MLTX) Globe Newswire 8:45 AM
MoonLake Immunotherapeutics (NASDAQ: MLTX) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit PRNewswire 8:36 AM
MLTX LEGAL ALERT: MoonLake Immunotherapeutics Hit with Securities Fraud Class Action due to Drug Trial Results -- Investors Notified to Contact BFA Law by December 15 Globe Newswire 7:07 AM
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm PRNewswire 4:28 AM
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX PRNewswire 4:25 AM

-- November 30, 2025 --

Faruqi & Faruqi Reminds MoonLake Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 - MLTX PRNewswire 9:35 AM

-- November 29, 2025 --

MLTX DEADLINE: ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - MLTX Globe Newswire 11:36 PM
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics Globe Newswire 8:29 AM
MLTX STOCK: Lose Money on Your MoonLake Immunotherapeutics Investment? Contact BFA Law about the Pending Securities Class Action before December 15 Deadline Globe Newswire 6:38 AM

-- November 28, 2025 --

MoonLake Immunotherapeutics' (MLTX) Stock Crashes 90%, Triggers Lawsuit After Reported Phase 3 Trial Data for Sole Drug Candidate -- Hagens Berman PRNewswire 5:50 PM

-- November 27, 2025 --

MLTX Deadline: MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit PRNewswire 11:48 AM
MLTX INVESTMENT: MoonLake Immunotherapeutics Investors with Losses may have Rights in Securities Class Action - Contact BFA Law by December 15 Deadline Globe Newswire 7:18 AM

-- November 26, 2025 --

MLTX DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages MoonLake Immunotherapeutics Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - MLTX Globe Newswire 4:18 PM
MoonLake Immunotherapeutics' (MLTX) Stock Crashes 90%, Triggers Lawsuit After Reported Phase 3 Trial Data for Sole Drug Candidate -- Hagens Berman PRNewswire 8:50 AM

-- November 25, 2025 --

MoonLake Immunotherapeutics' (MLTX) Reported Phase 3 Trial Data for Sole Drug Candidate, 90% Stock Crash Triggers Investor Suit -- Hagens Berman PRNewswire 4:31 PM
MoonLake Immunotherapeutics Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights - MLTX Globe Newswire 4:14 PM
MoonLake Immunotherapeutics Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights - MLTX PRNewswire 8:45 AM
INVESTOR REMINDER: Important MoonLake Immunotherapeutics Securities Class Action Deadline Approaching on December 15 for Investors with Losses - Contact BFA Law Globe Newswire 8:33 AM

-- November 24, 2025 --

Bragar Eagel & Squire, P.C. Urges Investors of aTyr, Marex, Cepton, and MoonLake to Inquire About Their Rights Before Upcoming Deadlines Globe Newswire 5:32 PM
Investors in MoonLake Immunotherapeutics Should Contact The Gross Law Firm Before December 15, 2025 to Discuss Your Rights - MLTX Globe Newswire 3:01 PM
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact The Gross Law Firm Before December 15, 2025 to Discuss Your Rights - MLTX PRNewswire 8:45 AM
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against MoonLake Immunotherapeutics (NASDAQ: MLTX) Globe Newswire 8:41 AM
INVESTOR ALERT: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Inquire About a Securities Fraud Class Action by December 15, 2025 PRNewswire 8:41 AM

-- November 23, 2025 --

MLTX COURT ALERT: MoonLake Immunotherapeutics Investors that Lost Money May have been Affected by Fraud -- Contact BFA Law by December 15 Globe Newswire 7:38 AM

-- November 22, 2025 --

MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit PRNewswire 1:23 PM
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - MLTX Globe Newswire 12:51 PM

-- November 21, 2025 --

MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PRNewswire 3:30 PM
MoonLake Immunotherapeutics' (MLTX) Reported Phase 3 Trial Data for Sole Drug Candidate, 90% Stock Crash Triggers Investor Suit -- Hagens Berman Globe Newswire 2:52 PM
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics PRNewswire 10:12 AM
MoonLake Immunotherapeutics Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MLTX PRNewswire 8:45 AM
MLTX SHAREHOLDERS: A Securities Class Action against MoonLake Immunotherapeutics has been Filed on behalf of Investors -- Contact BFA Law by December 15 Globe Newswire 6:08 AM
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX PRNewswire 1:24 AM
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm PRNewswire 1:19 AM

-- November 20, 2025 --

Lost Money on MoonLake Immunotherapeutics (MLTX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky Globe Newswire 4:25 PM
DEADLINE ALERT for ATYR, MLTX, BAX, JHX: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class Actions Globe Newswire 2:57 PM
MLTX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics Globe Newswire 2:18 PM
MLTX LAWSUIT ALERT: The Gross Law Firm Notifies MoonLake Immunotherapeutics Investors of a Class Action Lawsuit and Upcoming Deadline PRNewswire 8:45 AM

-- November 19, 2025 --

ROSEN, A LONGSTANDING LAW FIRM, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - MLTX Globe Newswire 5:18 PM
MLTX SHAREHOLDER NOTICE: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman Globe Newswire 4:54 PM
The Gross Law Firm Notifies MoonLake Immunotherapeutics Investors of a Class Action Lawsuit and Upcoming Deadline - MLTX Globe Newswire 4:40 PM
Deadline Alert: MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit Globe Newswire 12:54 PM
MLTX STOCK: MoonLake Immunotherapeutics Sued for Securities Fraud after Drug Trial Results Cause 90% Stock Drop -- Investors Notified to Contact BFA Law Globe Newswire 8:08 AM
Market Data Delayed 15 Minutes